Cellular, Molecular and Biomedical Reports

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Publication Ethics and Malpractice Statement

Peer Review Process

Peer Review Policy

Article Processing Charges

Publication Fee

Research Data Sharing Policies

Assignment - CC BY

Repository policy

Publisher’S Note

Processing Cycle

Informed Consent

Guidelines for Guest Editors

Editorial Policies (Appeals and Complaints)

Authors Benefits

The Policy of Screening for Plagiarism

Guiding Principles for Research Involving Animals and Human Beings

Open Access Policy

Copyright and license

Compliance with Ethical Standards

Practical Guide to the SI Units

Journal Metrics

FAQ

News

Related Links

Effect of unripe fruit extract of Momordica charantia on total cholesterol, total triglyceride and blood lipoproteins in the blood of rats with hyperlipidemia

Document Type : Original Article

Authors

1 Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran

2 Department of Clinical Biochemistry, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran

3 Department of Basic Veterinary Sciences, Faculty of Veterinary, University of Zabol, Zabol, Iran

4 Department of Statistics, Faculty of Sciences, University of Zabol, Zabol, Iran

Abstract

Hyperlipidemia is a major risk factor for the development of cardiovascular disease. In this study, the effects of an unripe fruit extract of Momordica charantia on total cholesterol, total triglyceride and lipoproteins in the blood of mice with hyperlipidemia were investigated. In this study, 28 adult male Wistar rats weighing 210 to 250 g were selected and randomly divided into four groups of seven. One group was on a normal diet and the other groups were fed a high-fat diet for 8 weeks to develop hyperlipidemia. Experimental groups in this study were included group 1: control, oral administration of normal food without any drugs or extracts. Group 2: hyperlipidemia mice, feeding with normal food. Group 3: hyperlipidemia mice with a diet containing 4%. Group 4: hyperlipidemia mice with a diet containing 8%. The animals were fed by gavage at a dose of 4% and 8% of M. charantia powder solution for 15 days. Blood samples were taken and the level of total cholesterol, total triglyceride, and high-density lipoproteins (HDL) were measured enzymatically. The amount of low-density lipoproteins was calculated by Friedewald's formula. Data were analyzed using the analysis of variance. Experimental results showed that immature fruit powder of M. charantia quarantine significantly reduced serum triglycerides in group 8% mice fed rats fed a high-fat diet. Moreover, immature fruit powder of M. charantia increased the level of high-density lipoproteins. There was a statistically significant difference between the level of cholesterol and the level of low-density proteins (LDL). The highest reduction belonged to the group receiving immature powder. The results of the experiment showed that the unripe fruit extract of M. charantia has strong antilipidemic effects on rats fed with a high-fat diet.

Graphical Abstract

Effect of unripe fruit extract of Momordica charantia on total cholesterol, total triglyceride and blood lipoproteins in the blood of rats with hyperlipidemia

Keywords

Main Subjects

Full Text

Selected author of this article by journal

ِDr. Arezou Ghahghaei
Sistan and Baluchestan University

Home Page

Scopus

Researchgate

Open Access

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

 

Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.

 

Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 18%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.


[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.
[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.
[3] There is no limit to the number of words in a letter.
[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.
[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments

[7] Letters will be answered as soon as possible

References
  1. VishnuVardhan Reddy M, Rajani A, Nikitha S, Thomas J, Hemamalini K (2014) Anti-hyperlipidemic activity of Trichopus zeylanicus leaves against high fat diet and triton X-100 induced hyperlipidemia. World J Pharm Pharm Sci 3:1017-1025. doi:Corpus ID: 74108366
  2. Matos SL, Paula Hd, Pedrosa ML, Santos RCd, Oliveira ELd, Chianca Júnior DA, Silva ME (2005) Dietary models for inducing hypercholesterolemia in rats. Brazilian archives of biology and technology 48(2):203-209
  3. Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M (2018) Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 276:98-108. doi:https://doi.org/10.1016/j.atherosclerosis.2018.07.014
  4. Yang N, Lin M, Wang B, Zeng W, He Y, Peng H, Zeng J, Wu Z, Zhong Y (2016) Low level of low-density lipoprotein cholesterol is related with increased hemorrhagic transformation after acute ischemic cerebral infarction. Eur Rev Med Pharmacol Sci 20(4):673-678
  5. Hayatghaibi H, Karimi I, Yousefi M (2008) Effect of Cannabis Sativa L. (Isfahan Variety) Powder on Serum Lipid Profile in Male Rats. Iranian Journal of Endocrinology and Metabolism 9(4):423-427
  6. Alimanesh Z, Alimanesh Z, Davari F, Shadmehri S, Ahmadi M, Hosseini SA, Dolati S, Far AH (2020) The Effect of Continued Training with Crocin on Apoptosis Markers in Liver Tissue of High Fat Diet Induced Diabetic Rats. Molecular & Cellular Biomechanics 17(4):155-163. doi:https://doi.org/10.32604/mcb.2020.011532
  7. Akinmoladun AC, Ibukun E, Afor E, Obuotor EM, Farombi E (2007) Phytochemical constituent and antioxidant activity of extract from the leaves of Ocimum gratissimum. Scientific Research and Essays 2(5):163-166. doi:https://doi.org/10.5897/SRE.9000731
  8. Alavi M, Rai M, Martinez F, Kahrizi D, Khan H, Rose Alencar de Menezes I, Douglas Melo Coutinho H, Costa JGM (2022) The efficiency of metal, metal oxide, and metalloid nanoparticles against cancer cells and bacterial pathogens: different mechanisms of action. Cellular, Molecular and Biomedical Reports 2(1):10-21. doi:10.55705/cmbr.2022.147090.1023
  9. Alavi M, Rai M (2021) Antisense RNA, the modified CRISPR-Cas9, and metal/metal oxide nanoparticles to inactivate pathogenic bacteria. Cellular, Molecular and Biomedical Reports 1(2):52-59. doi:https://doi.org/10.55705/cmbr.2021.142436.1014
  10. Alavi M, Adulrahman NA, Haleem AA, Al-Râwanduzi ADH, Khusro A, Abdelgawad MA, Ghoneim MM, Batiha GE-S, Kahrizi D, Martinez F, Koirala N (2022) Nanoformulations of curcumin and quercetin with silver nanoparticles for inactivation of bacteria. Cell Mol Biol 67(5):151-156. doi:https://doi.org/10.14715/cmb/2021.67.5.21
  11. Shabab S, Gholamnezhad Z, Mahmoudabady M (2021) Protective effects of medicinal plant against diabetes induced cardiac disorder: A review. Journal of Ethnopharmacology 265:113328. doi:https://doi.org/10.1016/j.jep.2020.113328
  12. Fazeli-Nasab B, Shahraki-Mojahed L, Sohail-beygi G, Ghafari M (2022) Evaluation of Antimicrobial Activity of Several Medicinal Plants Against Clinically Isolated Staphylococcus aureus from Humans and Sheep. Gene Cell Tissue 9(2):e118752. doi:https://doi.org/10.5812/gct.118752
  13. Fazeli-Nasab B, Shahraki-Mojahed L, Dahmardeh N (2022) Evaluation of antimicrobial activity of essential oil and ethanolic extract of 10 medicinal plants on Rathayibacter tritici and Xanthomonas translucens. Plant Biotechnology Persa 4(1):10-17
  14. Valizadeh M, ur Rehman F, Hassanzadeh MA, Beigomi M, Fazeli-Nasab B (2021) Investigating the Antimicrobial Effects of Glycyrrhiza glabra and Salvia officinalis Ethanolic Extract Against Helicobacter pylori. Int J Infect 8(4):e114563. doi:https://doi.org/10.5812/iji.114563
  15. Shanmugam S, Manikandan K, Rajendran K (2009) Ethnomedicinal survey of medicinal plants used for the treatment of diabetes and jaundice among the villagers of Sivagangai District, Tamilnadu. Ethnobotanical leaflets 13:189-194
  16. Mehrabi A-A, Fazeli-Nasab B (2012) In vitro culture of Allium scorodoprasum spp. Rotundum: callus induction, somatic embryogenesis and direct bulblet formation. Intl J Agri Crop Sci 4(1):1-7
  17. Fazeli-nasab B, Fooladvand Z (2014) Classification and Evaluation of medicinal plant and medicinal properties of mastic. International Journal of Advanced Biological and Biomedical Research 2(6):2155-2161
  18. Bortolotti M, Mercatelli D, Polito L (2019) Momordica charantia, a nutraceutical approach for inflammatory related diseases. Frontiers in pharmacology 10:486. doi:https://doi.org/10.3389/fphar.2019.00486
  19. Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D (2019) Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. Journal of Ethnopharmacology 231:311-324. doi:https://doi.org/10.1016/j.jep.2018.10.033
  20. Sur S, Ray RB (2020) Bitter melon (Momordica charantia), a nutraceutical approach for cancer prevention and therapy. Cancers 12(8):2064. doi:https://doi.org/10.3390/cancers12082064
  21. Chen F, Huang G, Huang H (2021) Preparation, analysis, antioxidant activities in vivo of phosphorylated polysaccharide from Momordica charantia. Carbohydrate polymers 252:117179. doi:https://doi.org/10.1016/j.carbpol.2020.117179
  22. Farina V, Gentile C, Sortino G, Gianguzzi G, Palazzolo E, Mazzaglia A (2020) Tree-ripe mango fruit: Physicochemical characterization, antioxidant properties and sensory profile of six Mediterranean-grown cultivars. Agronomy 10(6):884. doi:https://doi.org/10.3390/agronomy10060884
  23. Rohde C, Wittmann J, Kutter E (2018) Bacteriophages: A therapy concept against multi-drug–resistant bacteria. Surgical infections 19(8):737-744. doi:https://doi.org/10.1089/sur.2018.184
  24. Azeez SH, Jafar SN, Aziziaram Z, Fang L, Mawlood AH, Ercisli MF (2021) Insulin-producing cells from bone marrow stem cells versus injectable insulin for the treatment of rats with type I diabetes. Cellular, Molecular and Biomedical Reports 1(1):42-51. doi:10.55705/cmbr.2021.138888.1006
  25. Saravani K, Afshari M, Aminisefat A, Bameri O (2021) Blood Sugar Changes in Patients with Acute Drug Poisoning. Cell Mol Biomed Rep 1(2):91-97. doi:http://dx.doi.org/10.55705/cmbr.2021.146061.1022
  26. Thomford KP, Thomford AK, Yorke J, Yeboah R, Appiah AA (2021) Momordica charantia L. for hyperlipidaemia: A randomised controlled assessment of the Ghanaian herbal medicinal product MCP-1. Journal of Herbal Medicine 28:100453. doi:https://doi.org/10.1016/j.hermed.2021.100453
  27. Bajaj S (2018) RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017. International journal of diabetes in developing countries 38(1):1-115. doi:https://doi.org/10.1007/s13410-018-0604-7
  28. Cortez-Navarrete M, Martinez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-del Villar M (2018) Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus. Journal of medicinal food 21(7):672-677. doi:https://doi.org/10.1089/jmf.2017.0114
  29. Masi D, Spoltore ME, Rossetti R, Watanabe M, Tozzi R, Caputi A, Risi R, Balena A, Gandini O, Mariani S (2022) The Influence of Ketone Bodies on Circadian Processes Regarding Appetite, Sleep and Hormone Release: A Systematic Review of the Literature. Nutrients 14(7):1410. doi:https://doi.org/10.3390/nu14071410
  30. Giagulli VA, Castellana M, Murro I, Pelusi C, Guastamacchia E, Triggiani V, De Pergola G (2019) The role of diet and weight loss in improving secondary hypogonadism in men with obesity with or without type 2 diabetes mellitus. Nutrients 11(12):2975. doi:https://doi.org/10.3390/nu11122975
  31. Kardos D, Simon M, Vácz G, Hinsenkamp A, Holczer T, Cseh D, Sárközi A, Szenthe K, Bánáti F, Szathmary S (2019) The composition of hyperacute serum and platelet-rich plasma is markedly different despite the similar production method. International Journal of Molecular Sciences 20(3):721. doi:https://doi.org/10.3390/ijms20030721
  32. Fatahi-Azad F, Alaf-Akbari N, Zakheri A, Andalib S, Maleki-Dizaji N, Gharah-Baghian A, Ghorbani-Haghjou A, Fakhrjou A, Garjani AR (2010) Hypolipidemic and antioxidant effects of Securigera securidaca L. seed in high fat fed rats. Pharmaceutical Sciences 15(4):293-301
  33. Quideau S, Deffieux D, Douat‐Casassus C, Pouységu L (2011) Plant polyphenols: chemical properties, biological activities, and synthesis. Angewandte Chemie International Edition 50(3):586-621. doi:https://doi.org/10.1002/anie.201000044
  34. Shahrani M, Pilehvarian AA, Kheyri S, Asgari A, Farokhi E, Parvin N, Rafieian-Kopaei M (2009) Effects of Kelussia odoratissima Mozaffarian (KOM) extract on blood lipid in Balb/c mice. Journal of Shahrekord Uuniversity of Medical Sciences 10:50-56
  35. Ignarro LJ, Balestrieri ML, Napoli C (2007) Nutrition, physical activity, and cardiovascular disease: an update. Cardiovascular research 73(2):326-340. doi:https://doi.org/10.1016/j.cardiores.2006.06.030
  36. Fazeli-Nasab B, Valizadeh M, Hassanzadeh MA, Beigomi M (2021) Evaluation of the Antimicrobial Activity of Olive and Rosemary Leave Extracts Prepared with Different Solvents Against Antibiotic-Resistant Escherichia coli. Int J Infect 8(3):e114498. doi:https://doi.org/10.5812/iji.114498
  37. Dabek A, Wojtala M, Pirola L, Balcerczyk A (2020) Modulation of cellular biochemistry, epigenetics and metabolomics by ketone bodies. Implications of the ketogenic diet in the physiology of the organism and pathological states. Nutrients 12(3):788. doi:http://dx.doi.org/10.3390/nu12030788
  38. Dąbek A, Wojtala M, Pirola L, Balcerczyk A (2020) Modulation of cellular biochemistry, epigenetics and metabolomics by ketone bodies. Implications of the ketogenic diet in the physiology of the organism and pathological states. Nutrients 12(3):788. doi:https://doi.org/10.3390/nu12030788
  39. Marrelli M, Conforti F, Araniti F, Statti GA (2016) Effects of saponins on lipid metabolism: A review of potential health benefits in the treatment of obesity. Molecules 21(10):1404. doi:https://doi.org/10.3390/molecules21101404
  40. Cohn JS, Kamili A, Wat E, Chung RW, Tandy S (2010) Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications. Atherosclerosis Supplements 11(1):45-48. doi:https://doi.org/10.1016/j.atherosclerosissup.2010.04.004
  41. Silva Figueiredo P, Carla Inada A, Marcelino G, Maiara Lopes Cardozo C, de Cássia Freitas K, De Cássia Avellaneda Guimarães R, Pereira de Castro A, Aragão do Nascimento V, Aiko Hiane P (2017) Fatty acids consumption: the role metabolic aspects involved in obesity and its associated disorders. Nutrients 9(10):1158. doi:https://doi.org/10.3390/nu9101158
  42. Madani H, Ahmady Mahmoodabady N, Vahdati A (2005) Effects of hydroalchoholic extract of Anethum graveolens (Dill) on plasma glucose an lipid levels in diabetes induced rats. Iranian Journal of Diabetes and Metabolism 5(2):109-116
  43. Murray RK, Granner DK, Rodwell VW (2006) Harper''s illustrated biochemistry. vol 577.1 HAR.
  44. Gordon DJ, Knoke J, Probstfield J, Superko R, Tyroler H (1986) High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 74(6):1217-1225. doi:https://doi.org/10.1161/01.CIR.74.6.1217
  45. Adorni MP, Ronda N, Bernini F, Zimetti F (2021) High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives. Cells 10(3):574. doi:https://doi.org/10.3390/cells10030574
  46. Kontush A (2020) HDL and reverse remnant-cholesterol transport (RRT): relevance to cardiovascular disease. Trends in Molecular Medicine 26(12):1086-1100. doi:https://doi.org/10.1016/j.molmed.2020.07.005
Cellular, Molecular and Biomedical Reports
Volume 2, Issue 2
Cellular, Molecular and Biomedical Reports (Online ISSN: 2823-2550)
June 2022
Pages 74-86
Files
History
  • Receive Date: 22 April 2022
  • Revise Date: 24 March 2022
  • Accept Date: 21 May 2022
  • First Publish Date: 22 May 2022
Share
How to cite
Statistics